https://www.traditionrolex.com/28

Pharma

Export growth_India_TPCI
Revolutionizing Indian Industries: A closer look at PLI schemes

The Performance Linked Incentive (PLI) Schemes have showcased remarkable success, with exports under the targeted sectors exceeding Rs 3.20 lakh crore (US$ 38.5 billion). Major contributions come from...

Consumer goods trade
India’s consumer goods exports: At an inflexion point?

With policies that focus on sales performance and enhanced ease of doing business, India can aspire to replicate Chinese success in consumer goods....

Indian export pharma and food sector
Mixed bag for India’s exports so far in pandemic year

As India endeavours to stem the decline in exports of key sectors like engineering goods, gems & jewellery, readymade garments and leather, it has an opportunity to capitalise on the positive trend in...

Indo-Norway cooperation transcends traditional contours of trade

Helge Tryti, Commercial Counsellor, Royal Norwegian Embassy, elaborates on the future of Indo-Norway cooperation, which is strongly geared towards energy, marine resources green economy and shipping. ...

Tanaz Buhariwalla Ireland
Ireland is an attractive destination for growth-stage Indian startups

Tanaz Buhariwalla, Director, IDA Ireland, discusses Ireland’s key advantages as a business destination for Indian companies, including a business-friendly ecosystem, competitive costs, support for i...

Laura Demetris UK TPCI
UK and India have common interests in innovation & entrepreneurship

Laura Demetris, Deputy Director for Investment and Marketing - South Asia at British High Commission, envisions the India-UK relationship as highly symbiotic, with the two countries responsible for ha...

Indian pharma post-COVID: On the innovation trail?

Post-COVID-19, India needs to strengthen its pharma R&D ecosystem to tap into emerging drug development opportunities and changing paradigms in the new drug development framework.....

Sanjay Singh Partner – Deal Advisory, Head of Lifesciences, KPMG in India
Patent expiries present a US$ 212 bn opportunity for Indian pharma

Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG in India, identifies new generics opportunities, established manufacturing ecosystem, growing penetration of health insurance and ta...

TPCI-IBT-Business-Perspectives
China removes import tariffs on pharmaceutical products

Though a new guideline released by the General Office of the State Council, China has revised the registration and approval of pharmaceutical products to fasten the process, the implementation still n...


Subscribe To Newsletter

Get to know of latest happening in TPCI & in the world of trade and commerce